Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medassets Inc Reaffirms FY 2013 Guidance


Wednesday, 1 May 2013 04:04pm EDT 

Medassets Inc announced that for fiscal 2013, it confirms and expects total net revenue of between $670-$684 million, non-GAAP adjusted EBITDA of between $215-$225 million, GAAP diluted EPS $0.32-$0.42 and diluted non-GAAP adjusted EPS of $1.22-$1.32. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $680 million, EBITDA of $222 million and EPS of $1.29 for fiscal 2013. 

Company Quote

21.66
-0.18 -0.82%
31 Oct 2014